Page last updated: 2024-09-04

tariquidar and oc 144-093

tariquidar has been researched along with oc 144-093 in 2 studies

Compound Research Comparison

Studies
(tariquidar)
Trials
(tariquidar)
Recent Studies (post-2010)
(tariquidar)
Studies
(oc 144-093)
Trials
(oc 144-093)
Recent Studies (post-2010) (oc 144-093)
210161381121

Protein Interaction Comparison

ProteinTaxonomytariquidar (IC50)oc 144-093 (IC50)
ATP-dependent translocase ABCB1Homo sapiens (human)0.0316

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, P; Ecker, GF; Jabeen, I; Pleban, K; Rinner, U1
Callaghan, R; Mellor, HR; Modok, S1

Reviews

1 review(s) available for tariquidar and oc 144-093

ArticleYear
Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
    Current opinion in pharmacology, 2006, Volume: 6, Issue:4

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Clinical Trials as Topic; Cyclosporins; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Imidazoles; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplasms; Quinolines; RNA Interference

2006

Other Studies

1 other study(ies) available for tariquidar and oc 144-093

ArticleYear
Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.
    Journal of medicinal chemistry, 2012, Apr-12, Volume: 55, Issue:7

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzophenones; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Ligands; Models, Molecular; Molecular Conformation; Propafenone; Quantitative Structure-Activity Relationship; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship

2012